Up a level |
Stainthorpe, Angela ORCID: 0000-0002-2531-9371, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie ORCID: 0000-0003-0164-103X, Dundar, Yenal, McEntee, Joanne and Syndikus, Isabel
(2020)
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 4 (4).
pp. 563-574.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Stainthorpe, Angela, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Boland, Angela ORCID: 0000-0002-5435-8644, Beale, Sophie, Dundar, Yenal, Kotas, Eleanor, McEntee, Joanne and Isabel, Syndikus
(2018)
Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12).
[Report]
Eldabe, Sam, Nevitt, Sarah, Griffiths, Sara, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, Houten, Rachel ORCID: 0000-0002-4315-7732, Brookes, Morag, Kansal, Anu, Earle, Jenny et al (show 3 more authors)
(2023)
Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results From a Randomized Controlled Trial.
NEUROSURGERY, 92 (1).
pp. 75-82.
Eldabe, Sam, Duarte, Rui V, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, Houten, Rachel ORCID: 0000-0002-4315-7732, Jowett, Susan, Sandhu, Harbinder, Chadwick, Raymond, Brookes, Morag et al (show 7 more authors)
(2020)
Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? a randomised controlled trial.
Pain, 161 (12).
pp. 2820-2829.
Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454, Dundar, Yenal, Kotas, Eleanor and McEntee, Joanne
(2021)
Encorafenib with Binimetinib for the Treatment of Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 5 (1).
pp. 13-22.
Martin, Antony P ORCID: 0000-0003-4383-6038, Richards, Sarah, Haycox, Alan ORCID: 0000-0001-6659-4866, Houten, Rachel ORCID: 0000-0002-4315-7732, McLeod, Claire, Braithwaite, Barbara, Clark, Jack O, Bell, Joanne and Clark, Richard E ORCID: 0000-0002-1261-3299
(2016)
Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.
JOURNAL OF CLINICAL APHERESIS, 31 (5).
pp. 434-442.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Bagust, Adrian ORCID: 0000-0002-2142-5767, Richardson, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Hounsome, Juliet ORCID: 0000-0002-2026-3778, Duarte, Rui et al (show 1 more authors)
(2020)
Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation.
HEALTH TECHNOLOGY ASSESSMENT, 24 (2).
1-+.
Chaplin, Marty ORCID: 0000-0002-7097-8704, Bresnahan, Rebecca, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Houten, Rachel ORCID: 0000-0002-4315-7732, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley and Munot, Pinki
(2023)
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
PharmacoEconomics - Open, 7 (6).
pp. 863-875.
Bresnahan, Rebecca, Houten, Rachel ORCID: 0000-0002-4315-7732, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Nevitt, Sarah ORCID: 0000-0001-9988-2709, Mahon, James, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne et al (show 3 more authors)
(2023)
Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics - open, 7 (4).
pp. 525-536.
Bresnahan, Rebecca, Houten, Rachel, Mahon, James, Beale, Sophie, Nevitt, Sarah, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Bhattacharyya, Devarshi, Dundar, Yenal, McEntee, Joanne and Gandhi, Shreyans
(2021)
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria [ID3746].
[Report]
Duarte, Rui V, Houten, Rachel ORCID: 0000-0002-4315-7732, Nevitt, Sarah, Brookes, Morag, Bell, Jill, Earle, Jenny, Gulve, Ashish, Thomson, Simon, Baranidharan, Ganesan, North, Richard B et al (show 2 more authors)
(2022)
Screening trials of spinal cord stimulation for neuropathic pain in England-A budget impact analysis.
FRONTIERS IN PAIN RESEARCH, 3.
974904-.
Duarte, Rui V, Nevitt, Sarah, Houten, Rachel ORCID: 0000-0002-4315-7732, Brookes, Morag, Bell, Jill, Earle, Jenny, Taylor, Rod S and Eldabe, Sam
(2023)
Spinal Cord Stimulation for Neuropathic Pain in England From 2010 to 2020: A Hospital Episode Statistics Analysis.
NEUROMODULATION, 26 (1).
pp. 109-114.
Haycox, Alan ORCID: 0000-0001-6659-4866, Pirmohamed, Munir ORCID: 0000-0002-7534-7266, McLeod, Claire, Houten, Rachel ORCID: 0000-0002-4315-7732 and Richards, Sarah
(2014)
Through a Glass Darkly: Economics and Personalised Medicine.
PharmacoEconomics, 32 (11).
pp. 1055-1061.
Chadwick, Raymond, McNaughton, Rebekah, Eldabe, Sam, Baranidharan, Ganesan, Bell, Jill, Brookes, Morag, Duarte, Rui V, Earle, Jenny, Gulve, Ashish, Houten, Rachel ORCID: 0000-0002-4315-7732 et al (show 8 more authors)
(2021)
To Trial or Not to Trial Before Spinal Cord Stimulation for Chronic Neuropathic Pain: The Patients' View From the TRIAL-STIM Randomized Controlled Trial.
NEUROMODULATION, 24 (3).
pp. 459-470.
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Mahon, James, Chaplin, Marty ORCID: 0000-0002-7097-8704, Edwards, Katherine, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Marsden, Ashley, Malik, Zafar et al (show 1 more authors)
(2023)
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PHARMACOECONOMICS-OPEN, 7 (3).
pp. 345-358.
Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Mahon, James, Houten, Rachel, Edwards, Katherine, Donegan, Sarah, Boland, Angela, Beale, Sophie, Dundar, Yenal and Mcentee, Joanne
(2023)
Upadacitinib for treating moderately to severely active ulcerative colitis [ID3953].
[Report]
Houten, Rachel ORCID: 0000-0002-4315-7732, Fleeman, Nigel ORCID: 0000-0002-4637-9779, Kotas, Eleanor, Boland, Angela ORCID: 0000-0002-5435-8644, Lambe, Tosin ORCID: 0000-0002-6229-2454 and Duarte, Rui
(2021)
A systematic review of health state utility values for thyroid cancer.
QUALITY OF LIFE RESEARCH, 30 (3).
pp. 675-702.
Fleeman, Nigel ORCID: 0000-0002-4637-9779, Houten, Rachel ORCID: 0000-0002-4315-7732, Chaplin, Marty ORCID: 0000-0002-7097-8704, Beale, Sophie ORCID: 0000-0003-0164-103X, Boland, Angela ORCID: 0000-0002-5435-8644, Dundar, Yenal, Greenhalgh, Janette ORCID: 0000-0003-4812-1904, Duarte, Rui and Shenoy, Aditya
(2019)
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine.
BMC CANCER, 19 (1).
1209-.